Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
about
Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance.Galectin-12 in Cellular Differentiation, Apoptosis and Polarization.Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases.Significant Improvement in Cardiometabolic Health in Healthy Non-Obese Individuals during Caloric Restriction-induced Weight Loss and Weight Loss Maintenance.Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.The cell biology of systemic insulin function.An Extract of Russian Tarragon Prevents Obesity-Related Ectopic Lipid Accumulation.Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease.The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase.Dual extraction of mRNA and lipids from a single biological sample.Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance.Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivoDissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible ExplanationAltered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat dietFc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis
P2860
Q47106825-175EC05E-2D3B-4573-911D-7B50A0F3EFAFQ47216978-082FDEC6-7EC4-4882-BD98-FBCEFBF5B920Q47413881-4803ACF9-40DA-4F06-9536-1E23D1C6C7C3Q47655604-D4C82C6D-193D-4ABB-A9FE-DEC0A22395B5Q47709261-9F75B423-3B1E-4FF5-8C1A-32AFF927A1CFQ50068477-420082F7-2086-45FA-980B-E2B7FEE5C7E3Q51761242-B3DE7149-3B43-4EEE-A7B2-EDCBCA7FED05Q52603907-A81F8BD4-AE72-4FA7-A371-9A5A47E1A62CQ52687483-8E26F3A9-4856-48BF-826E-255A18FDB255Q53705753-47AB8D82-5EB4-4460-9C26-4CCD3CA20903Q54108559-783498C3-2BD1-4142-ADBD-3351907D595EQ55092943-CD3BD5D9-6713-46D8-BDFE-A52256F2DF33Q55387515-313B73F4-725A-435C-BC5C-4CEEDE59F2D7Q58722632-402A84D6-F6FA-4115-A06B-2DA9D1ED826DQ58729926-5AE2696D-D903-4A6A-B7EA-B15CF8B79870Q58778932-F818493D-7D69-43D2-8B99-2039F1E2B10DQ59138315-921529A8-BFD2-4E40-9319-53AC0265E0CF
P2860
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@en
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@nl
type
label
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@en
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@nl
prefLabel
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@en
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@nl
P2860
P1433
P1476
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
@en
P2093
Varman T Samuel
P2860
P356
10.1016/J.CMET.2017.08.002
P577
2017-08-29T00:00:00Z